Shoreline Biosciences, Inc., a biopharmaceutical company developing disease modifying iNK cell therapies for autoimmune ...

Stifel has downgraded Tempus AI (NASDAQ:TEM) to hold from buy, citing valuation and uncertainty about core growth in 2025.

Comedians Patton Oswalt and Tig Notaro co-headline a show at Stifel Theater for St. Louis' Flyover Comedy Festival on Nov. 15 ...

Crossmark Global Holdings Inc. raised its holdings in Stifel Financial Corp. (NYSE:SF – Free Report) by 12.8% in the third ...

Fintel reports that on November 15, 2024, Stifel initiated coverage of EMCOR Group (NYSE:EME) with a Buy recommendation.

With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...

The plaintiffs in the $2.35 million award from last week, Douglas Muhlbauer and related entities, sued Stifel Nicolaus last ...

Stifel Nicolaus analyst Jeffrey Stantial reiterated a Buy rating on Gambling.com (GAMB – Research Report) today and set a price target of ...

In a report released today, Brad Reback from Stifel Nicolaus maintained a Buy rating on Elastic (ESTC – Research Report), with a price ...

We recently compiled a list of the 15 AI News You Missed This Week. In this article, we are going to take a look at where ...

U.S. Ski and Snowboard made the announcement Thursday morning that Vonn will rejoin the team for the 2024-25 season.

Stifel Financial Corp's robust wealth management division drives over 60% of net revenue. Active acquisition strategy bolsters Stifel's market presence and service offerings. Regulatory ...